Treatment of type 2 diabetes in Latin America: a consensus statement by the medical associations of 17 Latin American countries

Authors:
  • JRJuan Rosas
    Juan Rosas
  • RLRuy Lyra
    Ruy Lyra
  • SCSaulo Cavalcanti
    Saulo Cavalcanti
  • FEFelix Escaño
    Felix Escaño
  • MTMarcos Tambasia
    Marcos Tambasia
  • EDElizabeth Duarte
    Elizabeth Duarte

Abstract
Latin America faces unique challenges in the treatment of type 2 diabetes mellitus. The Asociación Latinoamericana de Diabetes (Latin American Diabetes Association, ALAD) brought together medical associations in 17 countries in Latin America to produce a consensus statement regarding the treatment of type 2 diabetes. The goal of the document is to provide practical recommendations that will guide clinicians through a simple decision-making process for managing patients. The cornerstone elements for therapeutic decision making are: severity of hyperglycemia, clinical condition of the patient (stable or with metabolic decompensation), and body mass index. The consensus includes a section devoted specifically to patients with obesity. Information is presented as highly-relevant clinical questions. The algorithm is based on the scientific recommendations of the 2006 ALAD guidelines (a document prepared using an evidence-based approach) and data from recent randomized controlled studies.